Second, TBFS is a TCM compound, and network pharmacology analysis revealed that this prescription may act on COPD glucocorticoid resistance through a variety of signaling pathways and targets; however, this study only focused on the PI3K-Akt signaling pathway, and there may be a selection bias. The gene discussed is AKT1; the disease is chronic obstructive pulmonary disease.